| Product Code: ETC11635461 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, China continued to import significant quantities of cholesterol-lowering agents, with top suppliers including Puerto Rico, Metropolitan France, Germany, Spain, and Italy. Despite a high level of market concentration indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) from 2020 to 2024 was -2.06%. The growth rate in 2024 experienced a sharp decline of -26.63%, reflecting potential shifts in market dynamics or regulatory factors impacting the importation of these essential pharmaceutical products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cholesterol Lowering Agents Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cholesterol Lowering Agents Market Revenues & Volume, 2021 & 2031F |
3.3 China Cholesterol Lowering Agents Market - Industry Life Cycle |
3.4 China Cholesterol Lowering Agents Market - Porter's Five Forces |
3.5 China Cholesterol Lowering Agents Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 China Cholesterol Lowering Agents Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 China Cholesterol Lowering Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Cholesterol Lowering Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases and related risk factors in China |
4.2.2 Growing awareness about the importance of cholesterol management and preventive healthcare measures |
4.2.3 Rising disposable income leading to increased healthcare spending on cholesterol-lowering agents |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals and market entry |
4.3.2 Competition from alternative therapies and traditional Chinese medicine practices |
4.3.3 Concerns regarding the side effects and long-term safety of cholesterol-lowering agents |
5 China Cholesterol Lowering Agents Market Trends |
6 China Cholesterol Lowering Agents Market, By Types |
6.1 China Cholesterol Lowering Agents Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 China Cholesterol Lowering Agents Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 China Cholesterol Lowering Agents Market Revenues & Volume, By Statins, 2021 - 2031F |
6.1.4 China Cholesterol Lowering Agents Market Revenues & Volume, By Bile Acid Sequestrants, 2021 - 2031F |
6.1.5 China Cholesterol Lowering Agents Market Revenues & Volume, By Nicotinic Acid, 2021 - 2031F |
6.1.6 China Cholesterol Lowering Agents Market Revenues & Volume, By PCSK9 Inhibitors, 2021 - 2031F |
6.1.7 China Cholesterol Lowering Agents Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 China Cholesterol Lowering Agents Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 China Cholesterol Lowering Agents Market Revenues & Volume, By Hypercholesterolemia, 2021 - 2031F |
6.2.3 China Cholesterol Lowering Agents Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.4 China Cholesterol Lowering Agents Market Revenues & Volume, By Hyperlipidemia, 2021 - 2031F |
6.3 China Cholesterol Lowering Agents Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China Cholesterol Lowering Agents Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 China Cholesterol Lowering Agents Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 China Cholesterol Lowering Agents Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 China Cholesterol Lowering Agents Market Import-Export Trade Statistics |
7.1 China Cholesterol Lowering Agents Market Export to Major Countries |
7.2 China Cholesterol Lowering Agents Market Imports from Major Countries |
8 China Cholesterol Lowering Agents Market Key Performance Indicators |
8.1 Average prescription rate of cholesterol-lowering agents per healthcare provider |
8.2 Patient adherence and compliance rates to prescribed cholesterol-lowering treatments |
8.3 Number of research and development initiatives focused on innovative cholesterol-lowering agents |
9 China Cholesterol Lowering Agents Market - Opportunity Assessment |
9.1 China Cholesterol Lowering Agents Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 China Cholesterol Lowering Agents Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 China Cholesterol Lowering Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Cholesterol Lowering Agents Market - Competitive Landscape |
10.1 China Cholesterol Lowering Agents Market Revenue Share, By Companies, 2024 |
10.2 China Cholesterol Lowering Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here